Q Fever Hepatitis

What is Q fever hepatitis?

Q fever hepatitis is a liver inflammation that occurs as part of an infection with Coxiella burnetii, the bacterium that causes Q fever. The disease is transmitted to humans primarily from animals—most often cattle, sheep, and goats—through inhalation of contaminated dust, aerosolized birth fluids, urine, or feces. While many people with Q fever develop a mild, self‑limiting flu‑like illness, up to 30 % of acute cases develop liver involvement that ranges from mild elevation of liver enzymes to overt hepatitis with jaundice, right‑upper‑quadrant pain, and fatigue.

The condition is most common in agricultural workers, veterinarians, abattoir staff, and people living in rural areas, but travelers to endemic regions can also be affected. Q fever hepatitis is a clinical diagnosis supported by laboratory testing and imaging, and it can progress to chronic Q fever (endocarditis, vascular infections) if not treated appropriately.

Sources: CDC; Mayo Clinic; WHO.

Common Causes

Q fever hepatitis is caused specifically by infection with Coxiella burnetii. However, liver inflammation can arise from several related or co‑existing conditions that often coexist with or mimic Q fever hepatitis. Understanding these helps clinicians rule out other diagnoses.

• Inhalation of C. burnetii–containing aerosols (most common source)
• Direct contact with contaminated animal birth products (placenta, amniotic fluid)
• Consumption of unpasteurized dairy products from infected animals
• Laboratory exposure (research or diagnostic work with the organism)
• Co‑infection with hepatitis viruses (HBV, HCV) that can exacerbate liver injury
• Alcoholic liver disease that may lower the threshold for symptomatic hepatitis
• Autoimmune hepatitis – may present similarly and require differentiation
• Drug‑induced liver injury (e.g., acetaminophen, statins)
• Other zoonotic infections that cause hepatitis, such as leptospirosis or brucellosis
• Chronic Q fever (vascular infection, endocarditis) that can secondarily involve the liver

Associated Symptoms

When the liver is involved, patients often experience a constellation of systemic and hepatic signs. The most frequent accompanying symptoms include:

• Fever (often >38 °C) and chills
• Profound fatigue and malaise
• Right‑upper‑quadrant (RUQ) abdominal pain or tenderness
• Hepatomegaly (enlarged liver) palpable on exam
• Jaundice (yellowing of skin and eyes) in more severe cases
• Dark urine and pale stools (signs of biliary obstruction)
• Loss of appetite and nausea
• Headache, myalgias, and arthralgias
• Elevated liver enzymes (ALT, AST) often 2–5 times the upper limit of normal
• Positive serology for phase I and phase II antibodies against C. burnetii

These symptoms usually appear 2–3 weeks after exposure but can be delayed up to 6 weeks.

When to See a Doctor

Because early treatment reduces the risk of chronic disease, seek medical attention promptly if you notice any of the following:

• Fever lasting more than 48 hours without an obvious cause
• Persistent RUQ pain or tenderness
• Yellowing of the skin or eyes
• Dark urine, pale stools, or unexplained itching
• Sudden, severe fatigue that interferes with daily activities
• History of recent contact with livestock, birthing animals, or unpasteurized dairy
• Existing heart valve disease, vascular grafts, or immunosuppression (higher risk of chronic Q fever)

Diagnosis

Diagnosing Q fever hepatitis involves a combination of clinical suspicion, laboratory testing, and imaging.

1. Medical History & Physical Exam

• Detailed exposure history (farm work, animal contact, travel)
• Assessment for RUQ tenderness, hepatomegaly, and signs of systemic infection

2. Blood Tests

• Liver function panel – ALT, AST, alkaline phosphatase, bilirubin
• Complete blood count – may show leukocytosis or mild anemia
• Serology for C. burnetii – detection of phase II IgG/IgM (acute infection) and phase I IgG (chronic infection). A fourfold rise in titer over 2–3 weeks confirms recent infection.
• Polymerase chain reaction (PCR) – detects bacterial DNA in blood, useful early before antibodies develop.
• Screen for co‑existing hepatitis viruses (HBV, HCV) and other infections.

3. Imaging

• Ultrasound – evaluates liver size, echotexture, and excludes biliary obstruction.
• CT or MRI – reserved for atypical presentations or when complications (abscess, granulomas) are suspected.

4. Liver Biopsy (rare)

In persistent cases, a biopsy may reveal characteristic granulomatous inflammation with occasional necrosis. This is usually not required if serology is definitive.

Treatment Options

Prompt antimicrobial therapy is the cornerstone of treatment. The choice of drug, duration, and supportive measures depend on disease severity.

1. Antibiotic Therapy

• Doxycycline 100 mg orally twice daily for 14 days is the first‑line agent for acute Q fever hepatitis (CDC recommendation).
• Combination therapy – Doxycycline plus a fluoroquinolone (e.g., ciprofloxacin) may be used in severe liver involvement, though evidence is limited.
• Chronic Q fever (if serology shows high phase I IgG ≥1:800) requires prolonged treatment, typically doxycycline 100 mg twice daily plus hydroxychloroquine 200 mg three times daily for 18–24 months.

2. Supportive Care

• Hydration and electrolytes – especially if fever causes sweating.
• Analgesics such as acetaminophen (avoid >2 g/day to protect liver) for pain and fever.
• Rest and gradual return to activity as symptoms improve.
• Nutrition – a balanced diet with adequate protein to support liver regeneration.

3. Monitoring

• Repeat liver enzymes after 1–2 weeks of therapy to ensure a downward trend.
• Serologic titers at 3‑month intervals for chronic infection surveillance.
• Cardiac evaluation (echocardiogram) for patients with known valvular disease, as Q fever can seed heart valves.

Prevention Tips

Because Q fever is a zoonotic disease, prevention focuses on minimizing exposure to infected animals and their products.

• Use personal protective equipment (PPE)—mask (N95 or higher), goggles, gloves—when handling birthing fluids, placenta, or aborted materials.
• Implement proper farm hygiene—wetting down dusty areas, limiting aerosolization, and regularly cleaning animal housing.
• Vaccination—available in some countries (Australia, France) for high‑risk occupational groups. Check local health authority guidelines.
• Pasteurize dairy products before consumption.
• Restrict access to animal birthing areas for vulnerable individuals (pregnant women, immunocompromised).
• Educate workers about early symptoms and the importance of reporting febrile illnesses.
• Dispose of animal waste and birth products in sealed containers and follow veterinary‑recommended biosecurity measures.

Emergency Warning Signs

Key Take‑Home Points

• Q fever hepatitis is a liver manifestation of infection with Coxiella burnetii, typically transmitted from livestock.
• Symptoms include fever, fatigue, RUQ pain, and sometimes jaundice; liver enzyme elevation is a hallmark.
• Diagnosis relies on exposure history, serologic testing (phase I/II antibodies), PCR, and liver function tests.
• First‑line treatment is doxycycline for 14 days; chronic infection needs prolonged combination therapy.
• Preventive measures focus on PPE, hygiene, vaccination (where available), and avoiding unpasteurized dairy.
• Urgent medical evaluation is warranted for severe abdominal pain, high‑grade fever, or signs of hepatic failure.

For personalized advice, always discuss your symptoms and exposure history with a healthcare professional.

References: CDC. Q Fever (Coxiella burnetii). 2023; Mayo Clinic. Q fever. 2022; WHO. Q fever fact sheet. 2021; Cleveland Clinic. Hepatitis overview. 2022; European Journal of Clinical Microbiology & Infectious Diseases. 2020; Lancet Infectious Diseases. 2021.